June 19th 2025
In this video interview, Michael Daines, MD, explains phase 3 data for Panzyga (Octapharma) for pediatric acute- onset neuropsychiatric syndrome (PANS).
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Examining the effect of eating disorders in pregnancy on neurodevelopmental risk in infants
January 21st 2022Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.
Using a lifestyle approach to manage adolescent depression
October 10th 2021At the virtual 2021 American Academy of Pediatrics National Conference & Exhibition, Christina Low Kapalu, PhD, discusses evidence-based lifestyle interventions that should be part of an adolescent depression management and treatment plan.